✦ LIBER ✦

Clinical Safety of Moxifloxacin Ophthalmic Solution 0.5% (VIGAMOX®) in Pediatric and Nonpediatric Patients With Bacterial Conjunctivitis

✍ Scribed by Lewis H. Silver; Adrienne M. Woodside; Dawnelle B. Montgomery

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Besifloxacin Opht

✍ Marguerite B. McDonald; Eugene E. Protzko; Lynne S. Brunner; Timothy W. Morris; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 923 KB

Efficacy and safety of 0.5% levofloxacin

✍ S.J. Lichtenstein; M. Rinehart 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Efficacy and safety of 0.5% levofloxacin

✍ Steven J Lichtenstein; Mike Rinehart 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 393 KB

Efficacy and Safety of Besifloxacin Opht

✍ Timothy L. Comstock; Michael R. Paterno; Jennifer A. Lynch; Heleen H. DeCory; Da 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Safety and Tolerability of Besifloxacin

✍ Timothy L. Comstock; Michael R. Paterno; Jennifer A. Lynch; Heleen H. DeCory; Da 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Comparative clinical study of norfloxaci

✍ Jose Luis Tovilla; Fernando Avila; Jaime Quintero; Renzo Rhenals 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 323 KB